Effects of clusterin over-expression on metastatic progression and therapy in breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects of clusterin over-expression on metastatic progression and therapy in breast cancer ; volume:10 ; number:1 ; day:22 ; month:3 ; year:2010 ; pages:1-14 ; date:12.2010
BMC cancer ; 10, Heft 1 (22.3.2010), 1-14, 12.2010
- Urheber
-
Flanagan, Louise
- Beteiligte Personen und Organisationen
-
Whyte, Lorna
Chatterjee, Namita
Tenniswood, Martin
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-10-107
- URN
-
urn:nbn:de:1111-2016030358088
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Flanagan, Louise
- Whyte, Lorna
- Chatterjee, Namita
- Tenniswood, Martin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization
Overexpression of MACC1 and Its significance in human Breast Cancer Progression
S100A4 overexpression proves to be independent marker for breast cancer progression
C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer
Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer
YY1 suppresses FEN1 over-expression and drug resistance in breast cancer
Over-expression of SRD5A3 and its prognostic significance in breast cancer
NUCKS overexpression in breast cancer
Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma
Exosomal prognostic biomarkers predict metastatic progression and survival in breast cancer patients
Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization
Overexpression of MACC1 and Its significance in human Breast Cancer Progression
S100A4 overexpression proves to be independent marker for breast cancer progression
C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer
Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer
YY1 suppresses FEN1 over-expression and drug resistance in breast cancer
Over-expression of SRD5A3 and its prognostic significance in breast cancer
NUCKS overexpression in breast cancer
Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma
Exosomal prognostic biomarkers predict metastatic progression and survival in breast cancer patients
Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization
Overexpression of MACC1 and Its significance in human Breast Cancer Progression
S100A4 overexpression proves to be independent marker for breast cancer progression
C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer
Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer
YY1 suppresses FEN1 over-expression and drug resistance in breast cancer
Over-expression of SRD5A3 and its prognostic significance in breast cancer
NUCKS overexpression in breast cancer
Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma
Exosomal prognostic biomarkers predict metastatic progression and survival in breast cancer patients
Overexpression of PIK3R1 promotes hepatocellular carcinoma progression